M.F.
CโโHโโDโ
NโOโ
Storage Condition
Store at refrigerator (2-8ยฐC) for long term storage
Synonyms
Itopride-d6, 1346746-82-4
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Itopride-d6 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Itopride-d6 usage and description
Itopride D6 is a deuterium-labeled derivative of the gastroprokinetic agent, Itopride. It is primarily used to treat symptoms of functional dyspepsia, which include abdominal pain, bloating, and discomfort. Itopride D6 is an effective medication that works by increasing the movement of food through the digestive system, thereby improving digestion and reducing symptoms of dyspepsia.
The chemical structure of Itopride D6 is similar to that of Itopride, with the only difference being the deuterium label. This means that Itopride D6 behaves in the same way as Itopride, but with a slightly altered mass. Itopride D6 is a selective antagonist of the dopamine D2 receptor and an inhibitor of acetylcholinesterase, which increases the concentration of acetylcholine in the gastrointestinal tract, leading to enhanced gastric motility.
Itopride D6 is typically administered orally, with the recommended dose being 50-100mg taken three times a day, preferably before meals. It is rapidly absorbed in the gastrointestinal tract, and peak plasma concentrations are achieved within 1-2 hours of ingestion. Itopride D6 is metabolized extensively in the liver and excreted primarily through the urine.
In conclusion, Itopride D6 is a deuterium-labeled derivative of Itopride that is used to treat functional dyspepsia. It works by increasing gastric motility and improving digestion. It is administered orally and is rapidly absorbed in the gastrointestinal tract. Itopride D6 is metabolized in the liver and excreted through the urine.